Share this article
Share this article
ResearchAndMarkets.com s offering.
The global non-invasive prenatal testing market is currently witnessing strong growth. Non-invasive prenatal testing (NIPT) is a form of prenatal screening conducted on a pregnant woman s blood sample to detect the presence of fetal abnormalities. The test is primarily used to diagnose genetic disorders such as Down syndrome (or trisomy 21), Edwards syndrome (or trisomy 18), Patau syndrome (or trisomy 13) and Turner syndrome, by analyzing DNA fragments in the mother s blood. The procedure eliminates the need for various precarious and invasive procedures, such as chorionic villus sampling (CVS) and can be performed after nine weeks of pregnancy.